This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after ...

This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc.; Astellas; Alimera Sciences, Inc.; Ocular Therapeutix, Inc ...